网站综合信息 avastin.org
    • 标题:
    • Avastin (bevacizumab) Treatment for MC 
    • 关键字:
    •  
    • 描述:
    • Indications: Metastatic Colorectal Cancer (mCRC) Avastin, in combination with intravenous 5-FU– 
    • 域名信息
    • 域名年龄:23年12个月3天  注册日期:2001年03月16日  到期时间:
      邮箱:domain-management-d  电话:+1.6502251000
      注册商:CSC Corporate Domains, Inc. (R24-LROR) 
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • 雅虎
    •  
    •  
    •  
    • 搜搜
    •  
    •  
    •  
    • 搜狗
    •  
    •  
    • 评级:-/10  
    • 360搜索
    •  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • -  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • dmoz目录收录
    • -  
    • 流量走势图
    域名注册Whois信息

    avastin.org

    域名年龄: 23年12个月3天
    注册时间: 2001-03-16
    注 册 商: CSC Corporate Domains, Inc. (R24-LROR)
    注册邮箱: domain-management-d
    联系电话: +1.6502251000

    获取时间: 2014年12月12日 05:08:40
    Domain Name:AVASTIN.ORG
    Domain ID: D67887213-LROR
    Creation Date: 2001-03-16T02:11:54Z
    Updated Date: 2014-01-31T09:27:22Z
    Registry Expiry Date: 2015-03-16T02:11:54Z
    Sponsoring Registrar:CSC Corporate Domains, Inc. (R24-LROR)
    Sponsoring Registrar IANA ID: 299
    WHOIS Server:
    Referral URL:
    Domain Status: clientTransferProhibited
    Registrant ID:B12947628192422
    Registrant Name:GENENTECH, INC.
    Registrant Organization:GENENTECH, INC.
    Registrant Street: 1 DNA Way
    Registrant City:South San Francisco
    Registrant State/Province:CA
    Registrant Postal Code:94080-4918
    Registrant Country:US
    Registrant Phone:+1.6502251000
    Registrant Phone Ext:
    Registrant Fax:
    Registrant Fax Ext:
    Registrant Email:domain-management-d
    Admin ID:A12947627096333
    Admin Name:GENENTECH, INC. GENENTECH, INC.
    Admin Organization:GENENTECH, INC.
    Admin Street: 1 DNA Way
    Admin City:South San Francisco
    Admin State/Province:CA
    Admin Postal Code:94080-4918
    Admin Country:US
    Admin Phone:+1.6502251000
    Admin Phone Ext:
    Admin Fax:
    Admin Fax Ext:
    Admin Email:domain-management-d
    Tech ID:A12947627096334
    Tech Name:GENENTECH, INC. GENENTECH, INC.
    Tech Organization:GENENTECH, INC.
    Tech Street: 1 DNA Way
    Tech City:South San Francisco
    Tech State/Province:CA
    Tech Postal Code:94080-4918
    Tech Country:US
    Tech Phone:+1.6502251000
    Tech Phone Ext:
    Tech Fax:
    Tech Fax Ext:
    Tech Email:domain-management-d
    Name Server:DNADNS2E.GENE.COM
    Name Server:DNADNS3E.GENE.COM
    Name Server:DNADNS4E.GENE.COM
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    Name Server:
    DNSSEC:Unsigned

    Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to(a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
    同IP网站(同服务器)
    其他后缀域名
    • 顶级域名
    • 相关信息
    网站首页快照(纯文字版)
    抓取时间:2019年06月13日 07:51:31
    网址:http://avastin.org/
    标题:Avastin (bevacizumab) Treatment for MCRC, NSCLC, GBM and MRC
    关键字:
    描述:Indications: Metastatic Colorectal Cancer (mCRC) Avastin, in combination with intravenous 5-FU–based chemotherapy, is approved by the FDA for first- or second-line treatment of people with metas
    主体:
    Glossary
    on
    off
    Prescribing Information
     |
    Información En Español
    -
    AAA
    +
    print page
    e-mail page
    link to this page
    To:
    Enter a valid recipient name
    To:
    Enter a valid recipient email address
    From:
    Enter a valid name
    From:
    Enter a valid email address
    Message
    Enter a valid message
    X
    Send
     
     
    Colorectal Cancer
    Lung Cancer
    Glioblastoma
    Kidney Cancer
    Are you a
    Healthcare Provider?
     
     
     
     
     
     
     
     
     
     
     
     
    Avastin Support Line
    24/7 access to Oncology Nurses1-877-4AVASTIN
    Click here
     
    Coverage and Reimbursement
    Click here
     
    How Avastin is Designed to Work
    Click here
     
    Hear from Real Patients
    Click here
     
    Download Free Educational Materials
    Click here
     
     
     
    Indication
    Metastatic Colorectal Cancer (mCRC)
    Avastin, when started with the first or second intravenous 5-FU–based chemotherapy for a patient's metastatic cancer, is approved to treat metastatic colorectal cancer (mCRC).
    Non–Small Cell Lung Cancer (NSCLC)
    Avastin, in combination with carboplatin and paclitaxel, is approved to treat advanced nonsquamous non–small cell lung cancer (NSCLC) in people who have not yet received chemotherapy for their advanced disease. 
    Glioblastoma (GBM)
    Avastin is approved to treat glioblastoma (GBM) in adult patients whose cancer has progressed after prior treatment. The effectiveness of Avastin in GBM is based on tumor response. Currently, no data have shown whether or not Avastin improves disease-related symptoms or survival in people previously treated for GBM.
    Metastatic Kidney Cancer (mRCC)
    Avastin, used with interferon alfa, is approved to treat metastatic kidney cancer.
    Possible Serious Side Effects and Additional Important Safety Information
    What is the most serious safety information I should know about Avastin?
    Avastin can result in a serious, and sometimes fatal, side effect called gastrointestinal (GI) perforation. GI perforation is the development of a hole in the stomach, small intestine, or large intestine. Symptoms may include abdominal pain, nausea, vomiting, constipation, and fever. Avastin therapy should be stopped if GI perforation occurs.
    Treatment with Avastin can lead to slow or incomplete wound healing (for example, when a surgical incision has trouble healing or staying closed). In some cases, this event resulted in fatality. Stop Avastin for at least 28 days before voluntary surgery. Do not start Avastin for at least 28 days after surgery and until the surgical wound is fully healed. Avastin therapy should be stopped in patients who experience slow or incomplete wound healing.
    Treatment with Avastin can result in serious and sometimes fatal bleeding. This includes coughing up blood, bleeding in the stomach, vomiting blood, bleeding in the brain, nosebleeds, and vaginal bleeding. People who have recently coughed up blood or have serious bleeding should not receive Avastin.
    What are the additional possible seriou

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2025-03-08 17:15, Process in 0.0050 second.